首页> 外国专利> METHOD FOR ASSAYING IN VITRO THE PROTEOLYTIC ACTIVITY OF POLYPEPTIDES HAVING HCV NS3 PROTEASE ACTIVITY AND PEPTIDE SUBSTRATES TO BE USED IN THIS METHOD.

METHOD FOR ASSAYING IN VITRO THE PROTEOLYTIC ACTIVITY OF POLYPEPTIDES HAVING HCV NS3 PROTEASE ACTIVITY AND PEPTIDE SUBSTRATES TO BE USED IN THIS METHOD.

机译:体外评估具有HCV NS3蛋白酶活性和肽底物的多肽的蛋白水解活性的方法。

摘要

The process according to the present invention allows expression and isolation of polypeptides with the proteolytic activity of HCV NS3 protease in a pure, catalytically active form, and in amounts that are sufficient for discovery of NS3 protease inhibitors and for determination of the three-dimensional structure of the NS3 protease. A further subject of the present invention is a procedure that defines the chemical and physical conditions necessary for completion of the proteolytic activity of the above polypeptides. The invention further comprises new compositions of matter (expression vectors) containing nucleotide sequences capable of expressing the above mentioned polypeptides in culture cells. Finally, new compounds of matter are defined, suitable to measure the above proteolytic activity, and useful to develop NS3 protease inhibitors and therefore therapeutic agents for use against HCV. The figure shows the kinetic parameters of HCV NS3 protease using the S3 depsipeptide substrate (SEQ ID NO:45).
机译:根据本发明的方法允许以纯的催化活性形式表达和分离具有HCV NS3蛋白酶蛋白水解活性的多肽,并且其量足以发现NS3蛋白酶抑制剂和确定三维结构。的NS3蛋白酶。本发明的另一个主题是定义完成上述多肽的蛋白水解活性所必需的化学和物理条件的方法。本发明进一步包括含有能够在培养细胞中表达上述多肽的核苷酸序列的新的物质组合物(表达载体)。最后,定义了新的物质化合物,其适合于测量上述蛋白水解活性,并且可用于开发NS3蛋白酶抑制剂,从而开发抗HCV的治疗剂。该图显示了使用S3二肽底物(SEQ ID NO:45)的HCV NS3蛋白酶的动力学参数。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号